summary
Introduced
In Committee
Crossed Over
Passed
Dead
Signed/Enacted/Adopted
05/31/2013
05/31/2013
Introduced Session
2013 Regular Session
Bill Summary
Permits class II institutional pharmacy formulary to include include biologics, biosimilars, & biosimilar interchangeables; provides requirements for pharmacist to dispense substitute biological product that is determined to be biosimilar to & interchangeable for prescribed biological product; provides notification requirements for pharmacist in class II or modified class II institutional pharmacy; requires Board of Pharmacy to maintain current list of interchangeable biosimilar products.
Committee Categories
Health and Social Services
Sponsors (13)
Matt Hudson (R)*,
Shev Jones (D)*,
Larry Ahern (R),
Ben Albritton (R),
Jason Brodeur (R),
Matthew Caldwell (R),
Joseph Gibbons (D),
Ed Hooper (R),
Travis Hutson (R),
José Oliva (R),
Kathleen Peters (R),
Cary Pigman (R),
Daniel Raulerson (R),
Other Sponsors (2)
Health and Human Services Committee (H), Health Quality Subcommittee (H)
Last Action
Chapter No. 2013-102 (on 06/03/2013)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...